The ATHENA Trial - Will It Change Treatment Of Atrial Fibrillation

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Udgivelsesdato: 2009
OriginalsprogEngelsk
TidsskriftHealthcare Bulletin
Vol/bind1
Udgave nummer2
StatusUdgivet - 2009

Bibliografisk note

Atrial fibrillation is the most common arrhythmia encountered in clinical practice. In the ATHENA trial (A Placebo-Controlled, Double-Blind, Parallel Arm Trial to Assess the Efficacy of Dronedarone 400 mg bid for the Prevention...Author: Ole Dyg Pedersen, MD, DMSC, Christian Torp-Pedersen, MD, DMSC

ID: 20684618